Swiss National Bank Beam Therapeutics Inc. Transaction History

Swiss National Bank

  • $146 Billion
  • Q4 2024

A detailed history of Swiss National Bank transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Swiss National Bank holds 137,800 shares of BEAM stock, worth $3.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
137,800
Previous 136,700 0.8%
Holding current value
$3.66 Million
Previous $3.35 Million 2.03%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$21.55 - $30.35 $23,705 - $33,385
1,100 Added 0.8%
137,800 $3.42 Million
Q1 2024

May 07, 2024
BUY
$23.46 - $45.07 $96,186 - $184,787
4,100 Added 3.09%
136,700 $4.52 Million
Q4 2023

Feb 06, 2024
SELL
$17.69 - $30.76 $173,362 - $301,448
-9,800 Reduced 6.88%
132,600 $3.61 Million
Q3 2023

Nov 08, 2023
BUY
$23.01 - $32.46 $375,063 - $529,098
16,300 Added 12.93%
142,400 $3.42 Million
Q2 2023

Aug 09, 2023
BUY
$29.32 - $35.99 $129,008 - $158,356
4,400 Added 3.62%
126,100 $4.03 Million
Q1 2023

May 10, 2023
SELL
$30.15 - $48.79 $428,130 - $692,818
-14,200 Reduced 10.45%
121,700 $3.73 Million
Q4 2022

Feb 08, 2023
BUY
$36.73 - $51.6 $95,497 - $134,160
2,600 Added 1.95%
135,900 $5.32 Million
Q3 2022

Nov 09, 2022
BUY
$39.79 - $70.31 $190,992 - $337,488
4,800 Added 3.74%
133,300 $6.35 Million
Q2 2022

Aug 09, 2022
BUY
$29.86 - $62.36 $1.43 Million - $2.99 Million
47,900 Added 59.43%
128,500 $4.97 Million
Q1 2022

May 09, 2022
BUY
$53.73 - $82.16 $402,975 - $616,200
7,500 Added 10.26%
80,600 $4.62 Million
Q4 2021

Feb 08, 2022
BUY
$68.02 - $99.06 $265,278 - $386,334
3,900 Added 5.64%
73,100 $5.83 Million
Q3 2021

Nov 08, 2021
BUY
$84.37 - $133.6 $143,429 - $227,120
1,700 Added 2.52%
69,200 $6.02 Million
Q2 2021

Aug 06, 2021
BUY
$64.12 - $128.71 $1.78 Million - $3.58 Million
27,800 Added 70.03%
67,500 $8.69 Million
Q1 2021

May 07, 2021
BUY
$71.28 - $120.75 $99,792 - $169,050
1,400 Added 3.66%
39,700 $3.18 Million
Q4 2020

Feb 05, 2021
BUY
$22.24 - $95.63 $215,727 - $927,611
9,700 Added 33.92%
38,300 $3.13 Million
Q2 2020

Aug 05, 2020
BUY
$15.26 - $28.66 $436,436 - $819,676
28,600 New
28,600 $801,000

Others Institutions Holding BEAM

# of Institutions
242
Shares Held
76.7M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.87B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email